CHERN; Yijuang

Patent Applications and Registrations

Patent applications and USPTO patent grants for CHERN; Yijuang.The latest application filed is for "bipartite molecules and uses thereof in treating diseases associated with abnormal protein aggregates".

Company Profile

3.7.11

CHERN; Yijuang - Taipei TW

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bipartite Molecules And Uses Thereof In Treating Diseases Associated With Abnormal Protein Aggregates App 20210198332 - TU; Benjamin Pang-Hsien ; et al.	2021-07-01
Bipartite molecules and uses thereof in treating diseases associated with abnormal protein aggregates Grant 10,882,890 - Tu , et al. January 5, 2	2021-01-05
Dual-action compounds targeting adenosine A.sub.2A receptor and adenosine transporter for prevention and treatment of neurodegenerative diseases Grant 10,342,818 - Lin , et al. July 9, 2	2019-07-09
Compounds for use in prevention and treatment of neurodegenerative diseases and pain Grant 10,301,348 - Fang , et al.	2019-05-28
Methods and compositions for treating pain Grant 10,117,890 - Chen , et al. November 6, 2	2018-11-06
Bipartite Molecules And Uses Thereof In Treating Diseases Associated With Abnormal Protein Aggregates App 20180086801 - Tu; Benjamin Pang-hsien ; et al.	2018-03-29
Methods and Compositions for Treating Pain App 20170224716 - Chen; Chih-Cheng ; et al.	2017-08-10
Bipartite Molecules And Uses Thereof In Treating Diseases Associated With Abnormal Protein Aggregates App 20170226169 - Tu; Benjamin Pang-hsien ; et al.	2017-08-10
Dual-Action Compounds Targeting Adenosine A2A Receptor and Adenosine Transporter for Prevention and Treatment of Neurodegenerative Diseases App 20150374737 - LIN; Yun-Lian ; et al.	2015-12-31
Methods And Compositions For Treating Pain App 20150038445 - Chen; Chih-Cheng ; et al.	2015-02-05
Dual-Action Compounds Targeting Adenosine A2A Receptor and Adenosine Transporter for Prevention and Treatment of Neurodegenerative Diseases App 20120295863 - Lin; Yun-Lian ; et al.	2012-11-22
Method of making and using an adenosine analogue Grant 8,129,357 - Chern , et al. March 6, 2	2012-03-06
Method of making and using an adenosine analogue App 20080176816 - Chern; Yijuang ; et al.	2008-07-24
Therapeutic Gastrodia extracts Grant 7,351,434 - Chern , et al. April 1, 2	2008-04-01
Therapeutic gastrodia extracts App 20070237840 - Chern; Yijuang ; et al.	2007-10-11
Huntington's Disease Treatment Grant 7,220,729 - Chern May 22, 2	2007-05-22
Neurodegenerative disease treatment App 20050250673 - Chern, Yijuang	2005-11-10
Treatment of neurodegenerative diseases App 20040229837 - Chern, Yijuang ; et al.	2004-11-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.